Actively Recruiting
Impact of Physical Activity During Pregnancy on Cardiac Variability in Newborns
Led by University Hospital, Clermont-Ferrand · Updated on 2025-12-04
100
Participants Needed
1
Research Sites
180 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Ancillary study of the PregMouv study which aims to evaluate an intervention allowing the best adherence of women in terms of physical activity. Several types of interventions are therefore planned in this study: no intervention, physical activity sessions in person, by videoconference or mixed (in person and videoconference) with accelerometer assessment of the level of physical activity practiced (in the form of energy expenditure, in MET). Thus, for our ancillary study, a comparison of the cardiac variability of newborns will be carried out according to the level of physical activity practiced by the mother regardless of the intervention she benefited from within the framework of the PregMouv study. A comparison of the average saturation and the time spent below 90% saturation will be carried out via a continuous recording of saturation by oximetry. A longitudinal follow-up for the assessment of height and weight growth (from growth curves) and neurodevelopment (by clinical examination and self-questionnaire) is also planned until the child is 2 years old.
CONDITIONS
Official Title
Impact of Physical Activity During Pregnancy on Cardiac Variability in Newborns
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newborns of mothers who took part in the PregMouv study with at least one physical activity data point from T1 or T2 pregnancy
- Born at Clermont Ferrand University Hospital
- Parental agreement obtained for the child to participate
You will not qualify if you...
- Newborns needing aminergic support in the first days of life
- Conditions making heart rate variability analysis impossible
- Newborns who had invasive ventilatory support preventing oximetry recording analysis
- Parental refusal or inability to give consent for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000
Actively Recruiting
Research Team
L
Lise Laclautre
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here